204 related articles for article (PubMed ID: 21924052)
1. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
[TBL] [Abstract][Full Text] [Related]
2. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
[No Abstract] [Full Text] [Related]
3. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).
Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A
Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288
[TBL] [Abstract][Full Text] [Related]
5. Severe XLP Phenotype Caused by a Novel Intronic Mutation in the SH2D1A Gene.
Tóth B; Soltész B; Gyimesi E; Csorba G; Veres Á; Lányi Á; Kovács G; Maródi L; Erdős M
J Clin Immunol; 2015 Jan; 35(1):26-31. PubMed ID: 25491288
[TBL] [Abstract][Full Text] [Related]
6. SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses.
Sumazaki R; Kanegane H; Osaki M; Fukushima T; Tsuchida M; Matsukura H; Shinozaki K; Kimura H; Matsui A; Miyawaki T
Blood; 2001 Aug; 98(4):1268-70. PubMed ID: 11493483
[TBL] [Abstract][Full Text] [Related]
7. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.
Sun J; Ying W; Liu D; Hui X; Yu Y; Wang J; Wang X
Scand J Immunol; 2013 Nov; 78(5):463-7. PubMed ID: 23944711
[TBL] [Abstract][Full Text] [Related]
9. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
Jin YY; Zhou W; Tian ZQ; Chen TX
Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
[TBL] [Abstract][Full Text] [Related]
10. Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female.
Woon ST; Ameratunga R; Croxson M; Taylor G; Neas K; Edkins E; Browett P; Gane E; Munn S
Scand J Immunol; 2008 Aug; 68(2):153-8. PubMed ID: 18702745
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and gene research of X-linked lymphoproliferative disease in a Chinese family].
Zhu DX; Du J; Lan HK; Yu L; Feng ZC
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):244-8. PubMed ID: 17425868
[TBL] [Abstract][Full Text] [Related]
12. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
[TBL] [Abstract][Full Text] [Related]
13. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
Schuster V; Kreth HW
Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
[TBL] [Abstract][Full Text] [Related]
14. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
[TBL] [Abstract][Full Text] [Related]
15. Study of SH2D1A gene mutation in paediatric patients with B-cell lymphoma.
Koochakzadeh L; Hosseinverdi S; Hedayat M; Farahani F; Tofighi A; Eghbali M; Bidoki AZ; Izadyar M; Rahiminejad MS; Ramyar A; Aghamohammadi A; Rezaei N
Allergol Immunopathol (Madr); 2015; 43(6):568-70. PubMed ID: 25982576
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development.
Nagy N; Klein E
Immunol Lett; 2010 May; 130(1-2):13-8. PubMed ID: 20080127
[TBL] [Abstract][Full Text] [Related]
17. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
[TBL] [Abstract][Full Text] [Related]
18. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
[TBL] [Abstract][Full Text] [Related]
19. X-linked lymphoproliferative disease in an adult.
Hoshino T; Kanegane H; Doki N; Irisawa H; Sakura T; Nojima Y; Miyawaki S; Miyawaki T
Int J Hematol; 2005 Jul; 82(1):55-8. PubMed ID: 16105760
[TBL] [Abstract][Full Text] [Related]
20. X-linked lymphoproliferative disease: three atypical cases.
Nistala K; Gilmour KC; Cranston T; Davies EG; Goldblatt D; Gaspar HB; Jones AM
Clin Exp Immunol; 2001 Oct; 126(1):126-30. PubMed ID: 11678908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
